Functional Interactions Between YY1 and Adenovirus E1A
Overview
Authors
Affiliations
YY1 is a C2H2-type zinc finger transcription factor that is a member of the human GLl-Kruppel family of proteins. YY1 represses transcription when bound upstream of transcription initiation sites. The repression can be relieved by adenovirus E1A and activation of target genes occurs. We have mapped the repression domain of YY1 to the C-terminal region, overlapping its DNA binding domain. We have also identified an activation domain within the first 69 amino acids of YY1. The YY1 C-terminal region is involved in physical interactions with E1A and is functionally necessary for YY1 to respond to E1A. This suggests that relief of YY1 repression by E1A involves YY1-E1A physical interactions. Although not involved in interactions with E1A, the N-terminal activation domain is also necessary for YY1 to respond to E1A. Presumably, under repressing conditions, the activation domain is masked by the conformation of YY1, but is released upon binding of E1A and is required to subsequently activate transcription. Consistent with this hypothesis, an ATF-2-YY1 chimeric protein containing the activation domain of ATF-2 and the C-terminal two-thirds of YY1 is still a potent repressor. Unlike the mutant YY1 lacking its own N-terminal activation domain, the chimeric protein is fully responsive to E1A.
Liu R, Xu Z, Huang X, Xu B, Chen M Clin Transl Med. 2023; 13(10):e1422.
PMID: 37771187 PMC: 10539684. DOI: 10.1002/ctm2.1422.
Zinc Ions Modulate YY1 Activity: Relevance in Carcinogenesis.
Figiel M, Gorka A, Gorecki A Cancers (Basel). 2023; 15(17).
PMID: 37686614 PMC: 10487186. DOI: 10.3390/cancers15174338.
Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development.
Warowicka A, Broniarczyk J, Weglewska M, Kwasniewski W, Gozdzicka-Jozefiak A Int J Mol Sci. 2022; 23(7).
PMID: 35408813 PMC: 8998550. DOI: 10.3390/ijms23073453.
YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins.
Qiao S, Wang W, Yi C, Xu Q, Wang W, Shi J Cancers (Basel). 2022; 14(7).
PMID: 35406384 PMC: 8996997. DOI: 10.3390/cancers14071611.
Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development.
Yi C, Li G, Wang W, Sun Y, Zhang Y, Zhong C Cancers (Basel). 2021; 13(10).
PMID: 34065631 PMC: 8156467. DOI: 10.3390/cancers13102402.